- Briefly describe a specific question, or set of related questions, about a health care test or treatment that this program should consider.
For diabetic patients, what is the effectiveness of a routine care plan patient outreach compliance program
- Does your question include a comparison of different health care approaches? (If no, your topic will still be considered.)
yes
- If yes, explain the specific technologies, devices, drugs, or interventions you would like to see compared:
Aggressive patient outreach versus standard patient care
- What patients or group(s) of patients does your question apply to? (Please include specific details such as age range, gender, coexisting diagnoses, and indications for therapy.)
The test group will apply to patients with HbA1c's > 9.0
- Are there subgroups of patients that your question might apply to? (For example, an ethnic group, stage or severity of a disease.)
Hispanic adults between the ages of 21 and 72
- Describe the health-related benefits you are interested in. (For example, improvements in patient symptoms or problems from treatment or diagnosis.)
Reduction in A1c's to 7.0 from 9.0 or more
- Describe any health-related risks, side effects, or harms that you are concerned about.
there are no health related risks or harms
Appropriateness for EHC Program
- Does your question include a health care drug, intervention, device, or technology available (or likely to be available) in the U.S.?
no
- Which priority area(s) and population(s) does this topic apply to? (check all that apply)
-
- EHC Priority Conditions (updated in 2008)
- Diabetes mellitus
- AHRQ Priority Populations
- Low income groups
- Minority groups
- Women
- Federal Health Care Program
- Medicaid
- Medicare
Importance
- Describe why this topic is important.
May provide important information on the importantance of process in making patients compliant
- What specifically motivated you to ask this question? (For example, you are developing a clinical guideline, working with a policy with large uncertainty about the appropriate approach, costly intervention, new research you have read, items in the media you may have seen, a clinical practice dilemma you know of, etc.)
We are developing a trial with a Federally Qualified Clinic to test between visit patient management
- Does your question represent uncertainty for clinicians and/or policy-makers? (For example, variations in clinical care, controversy in what constitutes appropriate clinical care, or a policy decision.)
no
- If yes, please explain:
Potential Impact
- How will an answer to your research question be used or help inform decisions for you or your group?
The answer may help develop a better trial
- Describe the timeframe in which an answer to your question is needed.
ASAP
- Describe any health disparities, inequities, or impact on vulnerable populations your question applies to.
Nominator Information
- Other Information About You: (optional)
-
- Please choose a description that best describes your role or perspective: (you may select more than one category if appropriate)
The answer may help develop a better trial
- Are you making a suggestion as an individual or on behalf of an organization?
Organization
- Please tell us how you heard about the Effective Health Care Program